It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIO’s FA Score shows that 0 FA rating(s) are green whileCPT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIO’s TA Score shows that 4 TA indicator(s) are bullish while CPT’s TA Score has 4 bullish TA indicator(s).
BIO (@Medical/Nursing Services) experienced а +8.12% price change this week, while CPT (@Media Conglomerates) price change was +1.23% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.
The average weekly price growth across all stocks in the @Media Conglomerates industry was -0.06%. For the same industry, the average monthly price growth was -3.68%, and the average quarterly price growth was +2.48%.
BIO is expected to report earnings on Oct 23, 2025.
CPT is expected to report earnings on Oct 23, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Media Conglomerates (-0.06% weekly)Companies that operate in these three (or more) areas: broadcasting, cable TV, publishing and movies/entertainment. The companies usually have a large share in these markets. Walt Disney Co . is an example.
BIO | CPT | BIO / CPT | |
Capitalization | 7.59B | 11.4B | 67% |
EBITDA | 656M | 893M | 73% |
Gain YTD | -13.044 | -6.283 | 208% |
P/E Ratio | 25.76 | 74.70 | 34% |
Revenue | 2.55B | 1.56B | 164% |
Total Cash | 1.37B | 33.1M | 4,151% |
Total Debt | 1.41B | 3.83B | 37% |
BIO | CPT | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 68 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 69 | |
SMR RATING 1..100 | 83 | 85 | |
PRICE GROWTH RATING 1..100 | 46 | 63 | |
P/E GROWTH RATING 1..100 | 51 | 7 | |
SEASONALITY SCORE 1..100 | 50 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CPT's Valuation (63) in the Real Estate Investment Trusts industry is in the same range as BIO (81) in the Medical Specialties industry. This means that CPT’s stock grew similarly to BIO’s over the last 12 months.
CPT's Profit vs Risk Rating (69) in the Real Estate Investment Trusts industry is in the same range as BIO (100) in the Medical Specialties industry. This means that CPT’s stock grew similarly to BIO’s over the last 12 months.
BIO's SMR Rating (83) in the Medical Specialties industry is in the same range as CPT (85) in the Real Estate Investment Trusts industry. This means that BIO’s stock grew similarly to CPT’s over the last 12 months.
BIO's Price Growth Rating (46) in the Medical Specialties industry is in the same range as CPT (63) in the Real Estate Investment Trusts industry. This means that BIO’s stock grew similarly to CPT’s over the last 12 months.
CPT's P/E Growth Rating (7) in the Real Estate Investment Trusts industry is somewhat better than the same rating for BIO (51) in the Medical Specialties industry. This means that CPT’s stock grew somewhat faster than BIO’s over the last 12 months.
BIO | CPT | |
---|---|---|
RSI ODDS (%) | 2 days ago67% | 2 days ago42% |
Stochastic ODDS (%) | 2 days ago81% | 2 days ago58% |
Momentum ODDS (%) | 2 days ago71% | 2 days ago51% |
MACD ODDS (%) | 2 days ago67% | 2 days ago49% |
TrendWeek ODDS (%) | 2 days ago70% | 2 days ago62% |
TrendMonth ODDS (%) | 2 days ago69% | 2 days ago54% |
Advances ODDS (%) | 3 days ago69% | 4 days ago60% |
Declines ODDS (%) | 9 days ago67% | 6 days ago52% |
BollingerBands ODDS (%) | 2 days ago64% | 2 days ago59% |
Aroon ODDS (%) | 2 days ago64% | 6 days ago41% |